دورية أكاديمية
Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)
| العنوان: | Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS) |
|---|---|
| المؤلفون: | Gogas, Helen, Dummer, Reinhard, Ascierto, Paolo A, Arance, Ana, Mandala', Mario, Liszkay, Gabriella, Garbe, Claus, Schadendorf, Dirk, Krajsová, Ivana, Gutzmer, Ralf, Sileni, Vanna Chiarion, Dutriaux, Caroline, Yamazaki, Naoya, Loquai, Carmen, Queirolo, Paola, Jan de Willem, Groot, Sellier, Abir Tadmouri, Suissa, Jeanne, Murris, Juliette, Gollerkeri, Ashwin, Robert, Caroline, Flaherty, Keith T |
| المساهمون: | Gogas, Helen, Dummer, Reinhard, Ascierto, Paolo A, Arance, Ana, Mandala', Mario, Liszkay, Gabriella, Garbe, Clau, Schadendorf, Dirk, Krajsová, Ivana, Gutzmer, Ralf, Sileni, Vanna Chiarion, Dutriaux, Caroline, Yamazaki, Naoya, Loquai, Carmen, Queirolo, Paola, Jan de Willem, Groot, Sellier, Abir Tadmouri, Suissa, Jeanne, Murris, Juliette, Gollerkeri, Ashwin, Robert, Caroline, Flaherty, Keith T |
| سنة النشر: | 2021 |
| المجموعة: | IRIS Università degli Studi di Perugia |
| مصطلحات موضوعية: | BRAF(V600E−K) mutant Melanoma, BRAF/MEK inhibitors Combination, Encorafenib plus binimetinib, Health-related quality of life, Hospitalisation rate |
| الوصف: | In COLUMBUS, treatment with encorafenib plus binimetinib in patients with advanced BRAF-mutant melanomashowed improved progression-free and overall survival with favourable tolerability compared to vemurafenib treatment. Here, results on health-related quality of life (HRQoL) are presented. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/34091420; info:eu-repo/semantics/altIdentifier/wos/WOS:000678059500012; volume:152; firstpage:116-128; lastpage:128; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11391/1493907Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85107650414 |
| DOI: | 10.1016/j.ejca.2021.04.028 |
| الإتاحة: | https://doi.org/10.1016/j.ejca.2021.04.028Test http://hdl.handle.net/11391/1493907Test |
| رقم الانضمام: | edsbas.C63B6334 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.ejca.2021.04.028 |
|---|